Researchers report finding a key linkage between pain and brain molecule called glutamate, a discovery that lends new insight into fibromyalgia. In patients with fibromyalgia, researchers found, pain decreased when levels of glutamate went down.
Researchers at the
Following the four weeks of treatment, both clinical and experimental pain reported were reduced significantly. More importantly the reduction in both pain outcomes was linked with reductions in glutamate levels in a brain region called the insula 9: patients with greater reductions in pain showed greater reductions in glutamate. In other words, when pain decreased so did glutamate levels.
"If these findings are replicated, investigators performing clinical treatment trials in fibromyalgia could potentially use glutamate as a 'surrogate' marker of disease response," says lead author Richard E. Harris, PhD, a researcher at the